Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Fiore

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
Plos Computational Biology|January 16, 2026
TCR2HLA: Calibrated inference of HLA genotypes from TCR repertoires enables identification of immunologically relevant metaclonotypesKoshlan Mayer-Blackwell, Anastasia Minervina, Mikhail Pogorelyy, et al.
Vaccine Insights|April 24, 2023
The quest for vaccine-induced immune correlates of protection against tuberculosisElisa Nemes, Andrew Fiore-Gartland, Cesar Boggiano, et al.
Frontiers in Immunology|October 9, 2024
Co-regulation of innate and adaptive immune responses induced by ID93+GLA-SE vaccination in humansAndrew Fiore-Gartland, Himangi Srivastava, Aaron Seese, et al.
The Journal of Experimental Medicine|August 24, 2016
Balance between transmitted HLA preadapted and nonassociated polymorphisms is a major determinant of HIV-1 disease progressionDaniela C Mónaco, Dario A Dilernia, Andrew Fiore-Gartland, et al.
Plos Pathogens|March 15, 2021
Innate immune signatures to a partially-efficacious HIV vaccine predict correlates of HIV-1 infection riskErica Andersen-Nissen, Andrew Fiore-Gartland, Lamar Ballweber Fleming, et al.
Ebiomedicine|November 14, 2025
Unbiased cell clustering analysis of vaccine-induced T cell responses in the Imbokodo HIV-1 vaccine trialValentin Voillet, Janine van Duijn, Kanika Vanshylla, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|June 8, 2022
End-point definition and trial design to advance tuberculosis vaccine developmentAlberto L Garcia-Basteiro, Richard G White, Dereck Tait, et al.
Cell Reports. Medicine|August 8, 2023
mRNA vaccination boosts S-specific T cell memory and promotes expansion of CD45RA<sub>int</sub> T<sub>EMRA</sub>-like CD8<sup>+</sup> T cells in COVID-19 recovered individualsKoshlan Mayer-Blackwell, Heeju Ryu, Amy S Codd, et al.
Frontiers in Immunology|April 10, 2026
Profiling of SARS-CoV-2 virus shedding, antibody neutralization, and T-cell receptor repertoires in a large, multi-center cohort of young adults with varied prior exposuresAndrew Fiore-Gartland, Koshlan Mayer-Blackwell, James Stray, et al.
Ebiomedicine|February 2, 2024
Polytopic fractional delivery of an HIV vaccine alters cellular responses and results in increased epitope breadth in a phase 1 randomized trialMaurine D Miner, Allan deCamp, Nicole Grunenberg, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Plos Computational Biology|January 16, 2026
TCR2HLA: Calibrated inference of HLA genotypes from TCR repertoires enables identification of immunologically relevant metaclonotypesKoshlan Mayer-Blackwell, Anastasia Minervina, Mikhail Pogorelyy, et al.
Vaccine Insights|April 24, 2023
The quest for vaccine-induced immune correlates of protection against tuberculosisElisa Nemes, Andrew Fiore-Gartland, Cesar Boggiano, et al.
Frontiers in Immunology|October 9, 2024
Co-regulation of innate and adaptive immune responses induced by ID93+GLA-SE vaccination in humansAndrew Fiore-Gartland, Himangi Srivastava, Aaron Seese, et al.
The Journal of Experimental Medicine|August 24, 2016
Balance between transmitted HLA preadapted and nonassociated polymorphisms is a major determinant of HIV-1 disease progressionDaniela C Mónaco, Dario A Dilernia, Andrew Fiore-Gartland, et al.
Plos Pathogens|March 15, 2021
Innate immune signatures to a partially-efficacious HIV vaccine predict correlates of HIV-1 infection riskErica Andersen-Nissen, Andrew Fiore-Gartland, Lamar Ballweber Fleming, et al.
Ebiomedicine|November 14, 2025
Unbiased cell clustering analysis of vaccine-induced T cell responses in the Imbokodo HIV-1 vaccine trialValentin Voillet, Janine van Duijn, Kanika Vanshylla, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|June 8, 2022
End-point definition and trial design to advance tuberculosis vaccine developmentAlberto L Garcia-Basteiro, Richard G White, Dereck Tait, et al.
Cell Reports. Medicine|August 8, 2023
mRNA vaccination boosts S-specific T cell memory and promotes expansion of CD45RA<sub>int</sub> T<sub>EMRA</sub>-like CD8<sup>+</sup> T cells in COVID-19 recovered individualsKoshlan Mayer-Blackwell, Heeju Ryu, Amy S Codd, et al.
Frontiers in Immunology|April 10, 2026
Profiling of SARS-CoV-2 virus shedding, antibody neutralization, and T-cell receptor repertoires in a large, multi-center cohort of young adults with varied prior exposuresAndrew Fiore-Gartland, Koshlan Mayer-Blackwell, James Stray, et al.
Ebiomedicine|February 2, 2024
Polytopic fractional delivery of an HIV vaccine alters cellular responses and results in increased epitope breadth in a phase 1 randomized trialMaurine D Miner, Allan deCamp, Nicole Grunenberg, et al.
Pageof 8